✨ Your Portfolio is fetched and updated from zerodha.
Nano Hospitals

Dr Lalchandani Labs Ltd.

DLCL

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹9 Cr.
P/E
22.75

Dr Lalchandani Labs Ltd.

  • Dr Lalchandani Labs
  • DhanvantriJeevan Rek
  • Clinitech Laboratory

FAQs on Dr Lalchandani Labs Ltd. Shareprice

Dr Lalchandani Labs has given better returns compared to its competitors.
Dr Lalchandani Labs has grown at ~28.45% over the last 1yrs while peers have grown at a median rate of -41.78%

Dr Lalchandani Labs is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Dr Lalchandani Labs is 22.75, while 3 year average PE is 12.02.
Also latest EV/EBITDA of Dr Lalchandani Labs is 8.28 while 3yr average is 13.56.

View FAQ's On Business

Growth Table

  • Dr Lalchandani Labs Ltd.
  • DhanvantriJeevan Rek
  • Clinitech Laboratory

Balance Sheet

  • Dr Lalchandani Labs Ltd.
  • DhanvantriJeevan Rek
  • Clinitech Laboratory

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Dr Lalchandani Labs Ltd.
  • DhanvantriJeevan Rek
  • Clinitech Laboratory

Cash Flow

  • Dr Lalchandani Labs Ltd.
  • DhanvantriJeevan Rek
  • Clinitech Laboratory

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Dr Lalchandani Labs Ltd.
  • DhanvantriJeevan Rek
  • Clinitech Laboratory

Quarterly Results

  • Dr Lalchandani Labs Ltd.
  • DhanvantriJeevan Rek
  • Clinitech Laboratory

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Dr Lalchandani Labs Ltd. Financials

Balance sheet of Dr Lalchandani Labs is moderately strong.

Yes, The net debt of Dr Lalchandani Labs is increasing.
Latest net debt of Dr Lalchandani Labs is ₹1.07 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹0.56 Crs.

The profit is oscillating.
The profit of Dr Lalchandani Labs is ₹0.42 Crs for Mar 2025, ₹0.62 Crs for Mar 2024 and -₹1.56 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Dr Lalchandani Labs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech